Home | By sponsor

CENTER OF MOLECULAR IMMUNOLOGY

Trials shown by sponsor

Public title Date of Registration State
T1h in severe psoriasis-expanded access program (PUCE) 2012-07-20 Registered
h-R3 MAb combined with radio chemotherapy to treat non-surgical esophagus tumors of epithelial origin. 2010-12-29 Registered
NAcGM3/VSSP/Montanide ISA 51 formulation in HIV, phase II. 2010-12-29 Registered
Patients with non small cells lung cancer (NSCLC) and brain metastasis. 2010-12-29 Registered
hR3 MAb in combination with chemo-embolization in hepatocellular carcinoma. 2010-12-29 Registered
hR3 monoclonal antibody combined with chemoembolization in mestatatic liver treatment. 2010-12-29 Registered
14F7 MAb marked with Tc99 Phase II in breast tumors. 2010-12-29 Registered
Anti-idiotype 1E10 vaccine in advanced non- small cell lung (NSCLC) patients 2010-12-28 Registered
Anti-idiotype 1E10 vaccine in the treatment of patients with small cell lung (SCLC) patients 2010-12-28 Registered
h-R3 MaB and radiotherapy in pediatric patients with intrinsic diffuse astrocytomas of brain stem, phase II. 2010-12-28 Registered
hR3 MaB and radiotherapy in highly malignant astrocytic tumors, phase III. 2010-12-28 Registered
1E10 anti-idiotype vaccine, metastatic breast cancer, phase II 2010-12-27 Registered
Evaluation of Safety and Efficacy of T1h (anti-CD6) as Monotherapy and in Combination with Methotrexate in Patientes with Rheumatoid Arthritis 2010-12-27 Registered
188Re-marked Ior C5 MAb in persistent or relapsing ovary epithelial cancer, phase I. 2010-12-27 Registered
Clinical trial, phase II: Evaluation of TheraCIM hR3 MaB combined with chemo- and radio-therapy to treat patients with epithelial tumors in neck of the uterus, stage III. 2010-12-27 Registered
Toxicological evaluation of the humanized Anti-CD6 MAb T1h in Rheumatoid Arthritis Patients 2010-12-24 Registered
Advanced breast cancer treatment with hR3 monoclonal antibody combined with doxorubicin and cyclophosphamide, phase I. 2010-12-17 Registered
NGcGM3/VSSP/Montanide ISA 51 vaccine in metastatic breast cancer. Phase II 2010-12-17 Registered
99mtc-marked 14f7 MAb in colon/rectum tumor, Phase II 2010-12-17 Registered
NGcGM3/VSSP/Montanide ISA 51 vaccine for breast cancer IIa, IIb and IIIa surgically treated with positive ganglia and disease-free, Phase IIb/III. 2010-12-17 Registered